|
Sign In to gain access to subscriptions and/or personal tools.
|
Characterization of Uterine Leiomyomas in CD-1 Mice Following Developmental Exposure to Diethylstilbestrol (DES)
Retha R. Newbold
Developmental Endocrinology Section, Laboratory of Molecular Toxicology, Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Alicia B. Moore
Comparative Pathobiology Group, Laboratory of Experimental Pathology, Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Darlene Dixon
Comparative Pathobiology Group, Laboratory of Experimental Pathology, Environmental Toxicology Program, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, dixon{at}niehs.nih.gov
Experimental animal and clinical studies have well established the association of prenatal exposure to diethylstilbestrol (DES) and the subsequent development of reproductive tract abnormalities, including poor reproductive outcome and neoplasia. Overwhelmingly, the focus has been on DES-induced epithelial lesions, particularly vaginal adenosis and adenocarcinoma; however, uterine smooth muscle cells are also recognized as cellular targets of DES. This descriptive report characterizes uterine leiomyoma s that occur in outbred CD-1 mice following exposure to DES prenatally on days 9 to 16 of gestation or on neonatal days 1 to 5. These DES-induced uterine leiomyomas have typical histomorphologic, and some immunohistochemica l characteristics of spontaneously occurring uterine smooth muscle tumors of B6C3F1 mice previously described in our laboratory, and they are also similar to uterine leiomyomas (fibroids) commonly observed in premenopausal women.
Key Words: Diethylstilbestrol DES leiomyomas uterus mice growth factors.
References
- Aoyama H., Kato H., Dixon D. (1997). Specificity of antibodies against rodent transforming growth factor-
protein. J Histochem Cytochem 45: 695—701.[Abstract/Free Full Text] - Branham WS, Zehr DR, Chen JJ, Sheehan DM (1988). Alterations in developing rat uterine cell populations after neonatal exposure to estrogens and antiestrogens. Teratology 38: 271—279.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- . Brody JR, Cunha GR (1989). Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice II. Effects of DES on development. Am J Anat 186: 21—42.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Colborn T., Clement C. (1992). Chemically-Induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing Co., Princeton, NJ.
- Colborn T., Dumanski D., Myers JP (1996). Our Stolen Future. Penguin Books, New York, pp 1—294.
- Colborn T., vorn Saal FS, Soto AM ( 1993). Developmental effects of endocrine disrupting chemicals in wildlife and humans. Environ Health Perspect 101: 378—384.[Web of Science][Medline]
[Order article via Infotrieve]
- Cramer SF, Patel A. (1990). The frequency of uterine leiomyomas. Am J Clin Pathol 94: 435—438.[Web of Science][Medline]
[Order article via Infotrieve]
- Crum C., Cotran RS, Kumar V., Collins T. (1999). The female genital tract. In: Pathologic Basis of Disease, 6th edition, Cotran, Kumar, Collins (eds). WB Saunders, Philadelphia, PA, pp 1035—1091.
- Dixon D., Flake GP, Moore AB, He H., Haseman JK, Risinger JI, Lancaster JM, Berchuck A., Barrett JC, Robboy SJ Cell proliferation and apoptosis in human uterine leiomyomas and myometria Virchows Archiv 441: 53—62.
- Dixon D., He H., Haseman JK (2000). Immunohistochemica l localization of growth factors and their receptors in uterine leiomyomas and myometrium. Environ Health Perspect 108(5): 795—802.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Greenwell A., Foley JF, Maronpot RR (1991). An enhancement method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 59: 251—256.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Herbst AL, Bern HA ( 1981). Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. Thieme-Stratton, New York.
- Herbst AL, Ulfelder H., Poskanzer DC (1971). Adenocarcinoma of the vagina: Association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 284: 878—881.[Web of Science][Medline]
[Order article via Infotrieve]
- Kirkman H., Algard FT (1970). Characteristics of an androgen-estrogen- induced uterine smooth muscle cell tumor of the Syrian hamster. Cancer Res 30: 794—800.[Abstract/Free Full Text]
- Leavitt WW, Evans RW, Hendry WJ (1981). Etiology of DES-induced uterine tumors in the Syrian Hamster. Adv Exp Mol Biol 138: 63—86.
- McLachlan JA (1985). Estrogens in the Environment II: Influences on Development. Elsevier Press, New York.
- McLachlan JA, Newbold RR, Bullock BC (1980). Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40: 3988—3999.[Abstract/Free Full Text]
- McLachlan JA, Newbold RR, Shah HC, Hogan MD, Dixon RL (1982). Reduced fertility in female mice exposed transplacentally to diethylstilbestrol (DES). Fertil Steril 38(3): 364—371.[Web of Science][Medline]
[Order article via Infotrieve]
- Moore AB, He H., Yoshida A., Rico PJ, Haseman JK, Dixon D. (2000). Transforming growth factor-alpha, epidermal growth factor receptor, and PCNA immunoexpression in uterine leiomyosarcomas and leiomyomas in B6C3F1 mice. Exp Toxic Pathol 52: 195—200.[Web of Science][Medline]
[Order article via Infotrieve]
- Newbold RR (1995). Cellular and molecular effects of developmental exposure to diethylstilbestrol: Implications for other environmental estrogens. Environ Health Perspect 103: 83—87.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Newbold RR, Bullock BC, McLachlan JA (1990). Uterine adenocarcinom a in mice following developmental treatment with estrogens: A model for hormonal carcinogenesis. Cancer Res 50: 7677—7681.[Abstract/Free Full Text]
- Newbold RR, McLachlan JA (1982). Vaginal adenosi s and adenocarcinom a in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res 42: 2003—2011.[Abstract/Free Full Text]
- Newbold RR, McLachlan JA (1985). Diethylstilbestrol associated defects in murine genital tract development. In: Estrogens in the Environment, McLachlan JA (ed). Elsevier Science, New York, pp 288—318.
- Newbold RR, Tyrey S., Haney AF, McLachlan JA (1983). Developmentally arrested oviduct: A structural and functional defect in mice following prenatal exposure to diethylstilbestrol. Teratology 27: 417—426.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- . NIHPublicationNo. 00-4722(1999). DES Researchupdate:Currentknowledge, future directions. National Institute of Health, Bethesda, Maryland.
- Porter KB, Tsibris JC, Nicosia SV, Murphy JM, O'Brien WF, Rao PS, Spellacy WN (1995). Estrogen-induced guinea pig model for uterine leiomyomas: Do the ovaries protect? Biol Reprod 52: 824—832.[Abstract]
- Rosenthal A., Linquist PB, Bringman TS, Goeddel DV, Derynck R. (1986). Expression in rat fibroblasts of a human transforming growth factor-
results in transformation. Cell 46: 301—309.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve] - Tsutsui T., Barrett JC (1997). Neoplastic transformation of cultured mammalian cells by estrogens and estrogenlike chemicals. Environ Health Perspec 105(3): 619—624.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Yoshida A., Newbold RR, Dixon D. (1999). Effects of neonatal diethylstilbestrol (DES) exposure on morphology and growth patterns of endometrial epithelial cells in CD-1 mice. Toxicol Pathol 27: 325—333.[Abstract/Free Full Text]
Toxicologic Pathology, Vol. 30, No. 5,
611-616 (2002)
DOI: 10.1080/01926230290105839

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. S. Crabtree, S. A. Jelinsky, H. A. Harris, S. E. Choe, M. M. Cotreau, M. L. Kimberland, E. Wilson, K. A. Saraf, W. Liu, A. S. McCampbell, et al.
Comparison of Human and Rat Uterine Leiomyomata: Identification of a Dysregulated Mammalian Target of Rapamycin Pathway
Cancer Res.,
August 1, 2009;
69(15):
6171 - 6178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Diamanti-Kandarakis, J.-P. Bourguignon, L. C. Giudice, R. Hauser, G. S. Prins, A. M. Soto, R. T. Zoeller, and A. C. Gore
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Endocr. Rev.,
June 1, 2009;
30(4):
293 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N. Nierth-Simpson, M. M. Martin, T.-C. Chiang, L. I. Melnik, L. V. Rhodes, S. E. Muir, M. E. Burow, and J. A. McLachlan
Human Uterine Smooth Muscle and Leiomyoma Cells Differ in Their Rapid 17{beta}-Estradiol Signaling: Implications for Proliferation
Endocrinology,
May 1, 2009;
150(5):
2436 - 2445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.L. Greathouse, J.D. Cook, K. Lin, B.J. Davis, T.D. Berry, T.G. Bredfeldt, and C.L. Walker
Identification of Uterine Leiomyoma Genes Developmentally Reprogrammed by Neonatal Exposure to Diethylstilbestrol
Reproductive Sciences,
October 1, 2008;
15(8):
765 - 778.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Di, L. Yu, A.B. Moore, L. Castro, X. Zheng, T. Hermon, and D. Dixon
A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells
Hum. Reprod.,
August 1, 2008;
23(8):
1873 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Barlow, B. S. Mcintyre, and P. M.D. Foster
Male Reproductive Tract Lesions at 6, 12, and 18 Months of Age Following in Utero Exposure to Di(n-butyl) Phthalate
Toxicol Pathol,
January 1, 2004;
32(1):
79 - 90.
[Abstract]
[PDF]
|
 |
|
|
|